EMD-43660

Single-particle
3.1 Å
EMD-43660 Deposition: 08/02/2024
Map released: 27/03/2024
Last modified: 08/01/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-43660

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8vyg summary report (pdf.gz) Map-8vyg FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

SARS-CoV-2 S RBD (C.37 Lambda variant) plus S309 Fab, local refinement

EMD-43660

Single-particle
3.1 Å
EMD-43660 Deposition: 08/02/2024
Map released: 27/03/2024
Last modified: 08/01/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Sample: SARS-CoV-2 S C.37 (Lambda variant) plus S309, S2L20, and S2X303 Fabs
Fitted models: 8vyg

Deposition Authors: McCallum M , Veesler D , Seattle Structural Genomics Center for Infectious Disease (SSGCID)
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.
PUBMED: 38467646
DOI: doi:10.1038/s41467-024-46536-w
ISSN: 2041-1723
Grant Support: